共 50 条
- [5] Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2017, 13
- [6] Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey Allergy, Asthma & Clinical Immunology, 13
- [7] Hereditary Angioedema: Novel Molecules for Treatment of Acute Attacks and Long-Term Prophylaxis FUTURE PHARMACOLOGY, 2024, 4 (01): : 41 - 53